Logo image of ISRA

VANECK ISRAEL ETF (ISRA) Stock Overview

USA - NYSEARCA:ISRA - US92189F6354 - ETF

54.8416 USD
+0.03 (+0.06%)
Last: 10/3/2025, 8:04:00 PM
Fundamental Rating

5

Overall ISRA gets a fundamental rating of 5 out of 10. We evaluated ISRA against 81 industry peers in the Automobile Components industry. ISRA has only an average score on both its financial health and profitability. ISRA has a decent growth rate and is not valued too expensively. Finally ISRA also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ISRA had positive earnings in the past year.
ISRA had a positive operating cash flow in the past year.
In the past 5 years ISRA has always been profitable.
ISRA had a positive operating cash flow in each of the past 5 years.
ISRA Yearly Net Income VS EBIT VS OCF VS FCFISRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

With a Return On Assets value of 4.39%, ISRA perfoms like the industry average, outperforming 58.02% of the companies in the same industry.
ISRA has a Return On Equity (8.81%) which is in line with its industry peers.
With a Return On Invested Capital value of 8.17%, ISRA perfoms like the industry average, outperforming 54.32% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ISRA is in line with the industry average of 8.51%.
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROIC 8.17%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ISRA Yearly ROA, ROE, ROICISRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

ISRA has a Profit Margin of 5.84%. This is in the better half of the industry: ISRA outperforms 60.49% of its industry peers.
ISRA's Profit Margin has been stable in the last couple of years.
ISRA has a better Operating Margin (10.65%) than 61.73% of its industry peers.
In the last couple of years the Operating Margin of ISRA has remained more or less at the same level.
ISRA has a Gross Margin (27.60%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ISRA has remained more or less at the same level.
Industry RankSector Rank
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
ISRA Yearly Profit, Operating, Gross MarginsISRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

ISRA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ISRA has less shares outstanding
The number of shares outstanding for ISRA has been reduced compared to 5 years ago.
Compared to 1 year ago, ISRA has a worse debt to assets ratio.
ISRA Yearly Shares OutstandingISRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
ISRA Yearly Total Debt VS Total AssetsISRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

An Altman-Z score of 2.98 indicates that ISRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.98, ISRA is in the better half of the industry, outperforming 67.90% of the companies in the same industry.
ISRA has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as ISRA would need 6.05 years to pay back of all of its debts.
ISRA has a Debt to FCF ratio (6.05) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.32 indicates that ISRA is not too dependend on debt financing.
ISRA's Debt to Equity ratio of 0.32 is in line compared to the rest of the industry. ISRA outperforms 49.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Altman-Z 2.98
ROIC/WACC1.12
WACC7.29%
ISRA Yearly LT Debt VS Equity VS FCFISRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

ISRA has a Current Ratio of 1.80. This is a normal value and indicates that ISRA is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.80, ISRA is not doing good in the industry: 61.73% of the companies in the same industry are doing better.
A Quick Ratio of 1.12 indicates that ISRA should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.12, ISRA is not doing good in the industry: 62.96% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.12
ISRA Yearly Current Assets VS Current LiabilitesISRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

4

3. Growth

3.1 Past

ISRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.28%.
The Earnings Per Share has been growing slightly by 1.64% on average over the past years.
Looking at the last year, ISRA shows a decrease in Revenue. The Revenue has decreased by -3.62% in the last year.
Measured over the past years, ISRA shows a small growth in Revenue. The Revenue has been growing by 2.41% on average per year.
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%

3.2 Future

ISRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.63% yearly.
Based on estimates for the next years, ISRA will show a small growth in Revenue. The Revenue will grow by 2.56% on average per year.
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ISRA Yearly Revenue VS EstimatesISRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
ISRA Yearly EPS VS EstimatesISRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.34 indicates a rather expensive valuation of ISRA.
The rest of the industry has a similar Price/Earnings ratio as ISRA.
ISRA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.86, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 12.71, which indicates a correct valuation of ISRA.
The rest of the industry has a similar Price/Forward Earnings ratio as ISRA.
The average S&P500 Price/Forward Earnings ratio is at 23.32. ISRA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 21.34
Fwd PE 12.71
ISRA Price Earnings VS Forward Price EarningsISRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ISRA's Enterprise Value to EBITDA ratio is in line with the industry average.
ISRA's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 26.56
EV/EBITDA 7.55
ISRA Per share dataISRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ISRA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ISRA's earnings are expected to grow with 15.63% in the coming years.
PEG (NY)1.01
PEG (5Y)12.99
EPS Next 2Y18.35%
EPS Next 3Y15.63%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.41%, ISRA is a good candidate for dividend investing.
ISRA's Dividend Yield is rather good when compared to the industry average which is at 4.02. ISRA pays more dividend than 83.95% of the companies in the same industry.
ISRA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.41%

5.2 History

The dividend of ISRA is nicely growing with an annual growth rate of 7.84%!
ISRA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.84%
Div Incr Years0
Div Non Decr Years0
ISRA Yearly Dividends per shareISRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

62.40% of the earnings are spent on dividend by ISRA. This is not a sustainable payout ratio.
ISRA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP62.4%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
ISRA Yearly Income VS Free CF VS DividendISRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B
ISRA Dividend Payout.ISRA Dividend Payout, showing the Payout Ratio.ISRA Dividend Payout.PayoutRetained Earnings

VANECK ISRAEL ETF

NYSEARCA:ISRA (10/3/2025, 8:04:00 PM)

54.8416

+0.03 (+0.06%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)02-22 2026-02-22/amc
Inst Owners46.28%
Inst Owner Change-14.24%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap38.70B
Analysts80
Price Target63.97 (16.65%)
Short Float %0%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield 4.41%
Yearly Dividend1.59
Dividend Growth(5Y)7.84%
DP62.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.12%
PT rev (3m)19.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.32%
EPS NY rev (3m)-10.51%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE 21.34
Fwd PE 12.71
P/S 1.23
P/FCF 26.56
P/OCF 9.73
P/B 1.86
P/tB 2.52
EV/EBITDA 7.55
EPS(TTM)2.57
EY4.69%
EPS(NY)4.31
Fwd EY7.86%
FCF(TTM)2.07
FCFY3.77%
OCF(TTM)5.63
OCFY10.27%
SpS44.53
BVpS29.52
TBVpS21.73
PEG (NY)1.01
PEG (5Y)12.99
Profitability
Industry RankSector Rank
ROA 4.39%
ROE 8.81%
ROCE 10.41%
ROIC 8.17%
ROICexc 9.37%
ROICexgc 11.66%
OM 10.65%
PM (TTM) 5.84%
GM 27.6%
FCFM 4.64%
ROA(3y)5.45%
ROA(5y)4.73%
ROE(3y)10.95%
ROE(5y)10.02%
ROIC(3y)9.25%
ROIC(5y)8.5%
ROICexc(3y)10.37%
ROICexc(5y)9.81%
ROICexgc(3y)12.78%
ROICexgc(5y)12.13%
ROCE(3y)11.87%
ROCE(5y)10.97%
ROICexcg growth 3Y-1.65%
ROICexcg growth 5Y0.27%
ROICexc growth 3Y-2.16%
ROICexc growth 5Y0.21%
OM growth 3Y-2.46%
OM growth 5Y-1.24%
PM growth 3Y-3.58%
PM growth 5Y-0.79%
GM growth 3Y-0.99%
GM growth 5Y-0.59%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF 6.05
Debt/EBITDA 1.17
Cap/Depr 107.96%
Cap/Sales 8.01%
Interest Coverage 9.96
Cash Conversion 70%
Profit Quality 79.44%
Current Ratio 1.8
Quick Ratio 1.12
Altman-Z 2.98
F-Score5
WACC7.29%
ROIC/WACC1.12
Cap/Depr(3y)113.8%
Cap/Depr(5y)101.88%
Cap/Sales(3y)7.8%
Cap/Sales(5y)7.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.28%
EPS 3Y0.78%
EPS 5Y1.64%
EPS Q2Q%-26.88%
EPS Next Y21.13%
EPS Next 2Y18.35%
EPS Next 3Y15.63%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.62%
Revenue growth 3Y4.55%
Revenue growth 5Y2.41%
Sales Q2Q%-3.36%
Revenue Next Year-1.8%
Revenue Next 2Y0.24%
Revenue Next 3Y1.32%
Revenue Next 5Y2.56%
EBIT growth 1Y-17.5%
EBIT growth 3Y1.98%
EBIT growth 5Y1.14%
EBIT Next Year59.12%
EBIT Next 3Y22.78%
EBIT Next 5Y17.51%
FCF growth 1Y-20.46%
FCF growth 3Y21.5%
FCF growth 5Y7.22%
OCF growth 1Y-10.1%
OCF growth 3Y14.27%
OCF growth 5Y5.48%